COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

Reduce PAS

Purpose of Study

Assess the safety and effectiveness of the GSO device for the closure of atrial septal defects (ASDs) and patent foramen ovale (PFO)

Trial Status

Enrolling

Eligibility Criteria

Ages 18-70, diagnosed with an ischemic stroke within 1 year prior to enrollment, presence of PFO

Duration of Participation

Approximately 5 years

Contact Name: Jennifer Young, RN

Contact Phone: 515-633-3841

Contact Email: jyoung@iowaheart.com